Pharma Mar, S.A. (BME:PHM)
Spain flag Spain · Delayed Price · Currency is EUR
66.60
-0.65 (-0.97%)
Nov 16, 2026, 5:35 PM CET

Pharma Mar Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
68.3774.9926.131.1449.3692.86
Depreciation & Amortization
7.997.665.724.724.894.56
Other Amortization
0.360.361.051.031.011.03
Loss (Gain) From Sale of Assets
-0.75-0.75-0.841.93-0.010.03
Asset Writedown & Restructuring Costs
----1.751.48-0.18
Loss (Gain) From Sale of Investments
-0.33-0.33----
Stock-Based Compensation
---0.30.390.34
Other Operating Activities
5.08-19.8920.1114.099.42-11.55
Change in Accounts Receivable
-4.99-4.99-7.321.7821.61-26.76
Change in Inventory
-2.13-2.13-12.68-11.54-17.211.4
Change in Accounts Payable
-12.76-12.76-1.433.391.797.19
Change in Unearned Revenue
16.9916.99-24.93-23.2--
Change in Other Net Operating Assets
-25.01-60.21-5.34-34.41-43.23
Operating Cash Flow
52.853.136.03-13.4538.3225.68
Operating Cash Flow Growth
148.60%781.53%--49.24%-90.80%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-8.39-6.46-15.02-14.81-8.85-7.8
Sale of Property, Plant & Equipment
--0.89-0.01-
Sale (Purchase) of Intangibles
-2.92-2.92-0.5-1.15--
Investment in Securities
-33.59-56.3115.66-27.0919.7226.28
Other Investing Activities
0.074.9----
Investing Cash Flow
-44.82-60.791.03-43.0510.8818.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1.3315.417.21.545.83
Total Debt Issued
19.711.3315.417.21.545.83
Long-Term Debt Repaid
--5.66-9.56-8.36-10.2-15.27
Lease Payments
-1.91-1.91-2.12-2.01--
Net Debt Issued (Repaid)
16.58-4.335.86-1.15-8.66-9.44
Issuance of Common Stock
15.8715.8718.9118.6157.2333.55
Repurchase of Common Stock
-28.69-34.12-18.63-37.9-50.18-40.66
Common Dividends Paid
-17.33-13.95-11.42-11.69-11.76-10.87
Other Financing Activities
---0.07---
Financing Cash Flow
-13.57-36.52-5.35-32.14-13.37-27.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.42-1.241.51-1.160.640.4
Net Cash Flow
-5.17-45.423.22-89.7936.4717.14

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
44.4146.67-8.99-28.2529.4717.87
Free Cash Flow Growth
165.62%---64.87%-93.52%
Free Cash Flow Margin
18.71%21.08%-5.14%-17.87%15.01%7.78%
Free Cash Flow Per Share
2.562.67-0.51-1.581.630.99
Levered Free Cash Flow
20.2722.88-20.15-12.5933.114.75
Unlevered Free Cash Flow
20.7324.42-18.61-11.0834.66.86
Free Cash Flow After Leases
42.544.76-11.1-30.2629.4717.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.890.892.472.422.383.37
Cash Income Tax Paid
3.713.71-23.26-16.59-2.727.86
Change in Working Capital
-27.9-8.9-46.15-34.91-28.22-61.41